litlas
ログインアカウント作成

Peter C. Butler

1989–2022 年に発表

81
論文数
21,852
被引用数
72
h 指数
81
i10 指数

被引用数

Peter C. Butler の年別被引用数1974 年: 被引用 1 件1990 年: 被引用 1 件1991 年: 被引用 7 件1992 年: 被引用 8 件1993 年: 被引用 4 件1994 年: 被引用 5 件1995 年: 被引用 7 件1996 年: 被引用 5 件1997 年: 被引用 11 件1998 年: 被引用 11 件1999 年: 被引用 12 件2000 年: 被引用 34 件2001 年: 被引用 37 件2002 年: 被引用 39 件2003 年: 被引用 86 件2004 年: 被引用 122 件2005 年: 被引用 123 件2006 年: 被引用 210 件2007 年: 被引用 213 件2008 年: 被引用 342 件2009 年: 被引用 335 件2010 年: 被引用 294 件2011 年: 被引用 282 件2012 年: 被引用 299 件2013 年: 被引用 378 件2014 年: 被引用 329 件2015 年: 被引用 299 件2016 年: 被引用 240 件2017 年: 被引用 255 件2018 年: 被引用 205 件2019 年: 被引用 587 件2020 年: 被引用 584 件2021 年: 被引用 643 件2022 年: 被引用 463 件2023 年: 被引用 280 件2024 年: 被引用 454 件2025 年: 被引用 210 件2026 年: 被引用 7 件1975〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,245 件、この内訳の 29.6%中国: 引用元論文 555 件、この内訳の 7.3%イギリス: 引用元論文 488 件、この内訳の 6.4%イタリア: 引用元論文 373 件、この内訳の 4.9%ドイツ: 引用元論文 334 件、この内訳の 4.4%カナダ: 引用元論文 300 件、この内訳の 4%日本: 引用元論文 222 件、この内訳の 2.9%スウェーデン: 引用元論文 213 件、この内訳の 2.8%デンマーク: 引用元論文 203 件、この内訳の 2.7%インド: 引用元論文 192 件、この内訳の 2.5%オーストラリア: 引用元論文 184 件、この内訳の 2.4%スイス: 引用元論文 182 件、この内訳の 2.4%
0%29.6%その他 27.7%

機関

分野

  • Medicine74.5%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Neuroscience3.2%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Nursing0.7%
  • Immunology and Microbiology0.5%
  • その他2.8%

トピック

  • Pancreatic function and diabetes13.8%
  • Diabetes and associated disorders6.1%
  • Alzheimer's disease research and treatments6.1%
  • Diabetes Treatment and Management5.2%
  • Metabolism, Diabetes, and Cancer4.4%
  • Diabetes Management and Research4.2%
  • その他60.2%

共著者

全論文

検索で開く
  1. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

    著者: Alexandra E. Butler, Juliette Janson, Susan Bonner‐Weir, Robert Ritzel, Robert A. Rizza, Peter C. Butler - Diabetes 2003 被引用: 3,990

  2. Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

    著者: Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier, Robert M. Elashoff, Peter C. Butler - Gastroenterology 2011 被引用: 931

  3. Increased Risk of Type 2 Diabetes in Alzheimer Disease

    著者: Juliette Janson, Thomas Laedtke, Joseph E. Parisi, Peter C. O’Brien, Ronald C. Petersen, Peter C. Butler - Diabetes 2004 被引用: 956

  4. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

    著者: Rakez Kayed, Elizabeth Head, Floyd Sarsoza, Tommy Saing, Carl W. Cotman, Mihaela Necula, Lawrence Margol, Jessica Wu, Leonid Breydo, Jennifer L. Thompson, Suhail Rasool, Tatyana Gurlo, Peter C. Butler, Charles Glabe - Molecular Neurodegeneration 2007 被引用: 782

  5. Type 2 diabetes as a protein misfolding disease

    著者: Abhisek Mukherjee, Diego Morales‐Scheihing, Peter C. Butler, Claudio Soto - Trends in Molecular Medicine 2015 被引用: 341

  6. Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland

    著者: Belinda Gier, Peter C. Butler, Chi Lai, David Kirakossian, Matthew DeNicola, Michael W. Yeh - The Journal of Clinical Endocrinology & Metabolism 2011 被引用: 148

  7. Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model

    著者: Belinda Gier, Aleksey V. Matveyenko, David Kirakossian, David D. Dawson, Sarah Dry, Peter C. Butler - Diabetes 2012 被引用: 248

  8. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type‐2 diabetes

    著者: Yoshifumi Saisho, Alexandra E. Butler, Juris J. Meier, Travis Monchamp, Martin Allen-Auerbach, R. A. Rizza, Peter C. Butler - Clinical Anatomy 2007 被引用: 469

  9. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors

    著者: Alexandra E. Butler, Martha Campbell‐Thompson, Tatyana Gurlo, David W. Dawson, Mark A. Atkinson, Peter C. Butler - Diabetes 2013 被引用: 451

  10. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy

    著者: Alexandra E. Butler, L. Cao-Minh, Rocco Galasso, R. A. Rizza, Alberto Corradin, Claudio Cobelli, Peter C. Butler - Diabetologia 2010 被引用: 425

  11. β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

    著者: Juris J. Meier, Alexandra E. Butler, Yoshifumi Saisho, Travis Monchamp, Ryan Galasso, Anil Bhushan, Robert A. Rizza, Peter C. Butler - Diabetes 2008 被引用: 686

  12. β-Cell Mass and Turnover in Humans

    著者: Yoshifumi Saisho, Alexandra E. Butler, Erica Manesso, David Elashoff, Robert A. Rizza, Peter C. Butler - Diabetes Care 2012 被引用: 399

  13. A Critical Analysis of the Clinical Use of Incretin-Based Therapies

    著者: Peter C. Butler, Michael Elashoff, Robert M. Elashoff, Edwin Gale - Diabetes Care 2013 被引用: 296

  14. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes

    著者: Leslie S. Satin, Peter C. Butler, Joon Ha, Arthur Sherman - Molecular Aspects of Medicine 2015 被引用: 239

  15. Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

    著者: Leena Haataja, Tatyana Gurlo, Chang Jiang Huang, Peter C. Butler - Endocrine Reviews 2008 被引用: 602

  16. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1

    著者: Gerard A. Potter, L. H. Patterson, E Wanogho, J. Jefferson P. Perry, Peter C. Butler, Taeeba Ijaz, Ketan C. Ruparelia, John H. Lamb, P. B. Farmer, Lesley A. Stanley, M.D. Burke - British Journal of Cancer 2002 被引用: 375

  17. Activation of the HIF1α/PFKFB3 stress response pathway in beta cells in type 1 diabetes

    著者: Hiroshi Nomoto, Lina Pei, Chiara Montemurro, Madeline Rosenberger, Allison Furterer, Giovanni Coppola, Brian B. Nadel, Matteo Pellegrini, Tatyana Gurlo, Peter C. Butler, Slavica Tudzarova - Diabetologia 2019 被引用: 68

  18. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

    著者: Juris J. Meier, Anil Bhushan, Alexandra E. Butler, R. A. Rizza, Peter C. Butler - Diabetologia 2005 被引用: 491

  19. Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity

    著者: Jacqueline F. Rivera, Safia Costes, Tatyana Gurlo, Charles Glabe, Peter C. Butler - Journal of Clinical Investigation 2014 被引用: 205

  20. Live-cell imaging of glucose-induced metabolic coupling of β and α cell metabolism in health and type 2 diabetes

    著者: Zhongying Wang, Tatyana Gurlo, Aleksey V. Matveyenko, David Elashoff, Peiyu Wang, Madeline Rosenberger, Jason A. Junge, Raymond C. Stevens, Kate L. White, Scott E. Fraser, Peter C. Butler - Communications Biology 2021 被引用: 42

  21. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function

    著者: Chiara Montemurro, Hiroshi Nomoto, Lina Pei, Vishal S. Parekh, Kenny Vongbunyong, Suryakiran Vadrevu, Tatyana Gurlo, Alexandra E. Butler, Rohan Subramaniam, Eleni Ritou, Orian S. Shirihai, Leslie S. Satin, Peter C. Butler, Slavica Tudzarova - Nature Communications 2019 被引用: 87

  22. High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress–Mediated β-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes

    著者: Chang-jiang Huang, Chia‐Yu Lin, Leena Haataja, Tatyana Gurlo, Alexandra E. Butler, Robert A. Rizza, Peter C. Butler - Diabetes 2007 被引用: 410

  23. Reversing type 1 diabetes with stem cell–derived islets: a step closer to the dream?

    著者: Peter C. Butler, Edwin Gale - Journal of Clinical Investigation 2022 被引用: 19

  24. Relationship between β‐cell mass and diabetes onset

    著者: Aleksey V. Matveyenko, Peter C. Butler - Diabetes Obesity and Metabolism 2008 被引用: 244